Bile Acids as Novel Vascular Signalling Molecules and Therapeutic Target
Guardado en:
Autores principales: | A Jomard, O Chavez-Talavera, P Doytcheva, A Tailleux, C Wolfrum, T Lutz, F Ruschitzka, A von Eckardstein, B Staels, E Osto |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/636c6103e5ba48b7b7a379bd5b945dbe |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Unmasking Adenosine: The Purinergic Signalling Molecule Critical to Arrhythmia Pathophysiology and Management
por: Gareth DK Matthews, et al.
Publicado: (2020) -
Historical Overview of Vascular Allograft Transplantation
por: Kerbi Alejandro Guevara-Noriega, et al.
Publicado: (2019) -
Vascular Complications of Transradial Access for Cardiac Catheterization
por: Tanawan Riangwiwat, et al.
Publicado: (2021) -
The Role of Wearable Technologies and Telemonitoring in Managing Vascular Disease
por: Calvin Chan, et al.
Publicado: (2020) -
Right Ventricular Failure: Pathophysiology, Diagnosis and Treatment
por: Mattia Arrigo, et al.
Publicado: (2019)